Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E M, Kuchinskaya"'
Autor:
A. S. Fedorov, Yu. O. Savelyeva, Yu. Yu. Grabovetskay, L. A. Rudyuk, E. M. Kuchinskaya, M. M. Kostik
Publikováno v:
Современная ревматология, Vol 18, Iss 2, Pp 81-87 (2024)
Drug-induced hypersensitivity syndrome (DIHS) or drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, potentially fatal systemic reaction characterized by multiorgan damage involving the liver, hematopoietic system and skin, and h
Externí odkaz:
https://doaj.org/article/36601aff2b684f0aac517e6a70af611c
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 101-107 (2020)
The paper presents data on the pathogenesis of systemic lupus erythematosus (SLE), and depicts various molecular mechanisms for the development of SLE and lupus-like syndromes. It describes groups of diseases, such as apoptotic defects; NETosis; inte
Externí odkaz:
https://doaj.org/article/fb3533fafc9242f4b06b90e53f2e3b55
Autor:
E. M. Kalashnikova, R. K. Raupov, N. A. Lyubimova, E. M. Kuchinskaya, V. V. Masalova, E. A. Isupova, E. V. Gaidar, M. F. Dubko, L. S. Snegireva, L. S. Sorokina, T. L. Kornishina, M. A. Kaneva, I. A. Chikova, T. S. Likhacheva, O. L. Kolobova, O. V. Kalashnikova, V. G. Chasnyk, M. M. Kostik
Publikováno v:
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 68:74-84
Systemic lupus erythematosus is an immunopathological disease which is characterized by a poor prognosis. Biologics applied in the disease treatment allow reducing the corticosteroid toxicity and controlling the disease.Purpose. To evaluate the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::843dd991e9eb07d415bc1a8d60906560
https://doi.org/10.21508/1027-4065-2023-68-1-74-84
https://doi.org/10.21508/1027-4065-2023-68-1-74-84
Autor:
E. M. Kuchinskaya, A. M. Nikonenko
Publikováno v:
Russian Journal for Personalized Medicine. 2:85-89
Behcet disease is autoimmune vasculitis with predominantly mucocutaneous manifestations; eye, gastrointestinal and nervous system involvement is also possible. Behcet disease is relatively rare in pediatric population.This article presents the case o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::955367f487c5e7931c1d61dd2280f027
https://doi.org/10.18705/2782-3806-2022-2-5-85-89
https://doi.org/10.18705/2782-3806-2022-2-5-85-89
Autor:
M. M. Kostik, M. F. Dubko, L. S. Snegireva, V. V. Masalova, T. L. Kornishina, T. S. Likhacheva, I. A. Chikova, E. A. Isupova, E. M. Kuchinskaya, N. I. Glebova, O. V. Kalashnikova, V. G. Chasnykh
Publikováno v:
Вопросы современной педиатрии, Vol 12, Iss 5, Pp 18-23 (2013)
Aim: to perform retrospective evaluation of tocilizumab (TCZ) treatment every 2 and 4 weeks. Patients and methods: 33 children with systemic juvenile idiopathic arthritis (sJIA) were observed. Results: children, who need TCZ treatment every 2 weeks h
Externí odkaz:
https://doaj.org/article/38b644be909b44d6ab4d49f702470992
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 66(5)
Type 1 interferons (IFN1) are both key molecules of antiviral defense and potent inflammatory mediators. In 2003, increased expression of a variety of interferon 1-regulated genes was observed in a blood cells of patients with systemic lupus erythema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09d0867855e232212c3f367e8e3e2473
https://pubmed.ncbi.nlm.nih.gov/34047513
https://pubmed.ncbi.nlm.nih.gov/34047513